series-a
Stage
1
Investors
About
Shaping tomorrow’s genetic medicines by pioneering a new category of biotechnology to treat and prevent disease.
Explore Serif Biomedicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.